Blog

There are certain conditions that are known to impact one gender or the other more prominently, and a good example is Alzheimer’s disease. Of over 6 million Americans currently living with Alzheimer’s dementia, almost a full two-thirds are women, with barely one third men. At AGA Clinical Trials, Alzheimer’s disease is just one of the new…

In parts one and two of this multi-part blog series, we've gone over a number of details to be aware of when it comes to resistant hypertension. This condition, which refers to high blood pressure that is not responding to various forms of medical treatment, presents significant health risks to people who deal with it,...

In part one of this multi-part blog series, we went over some basics on a common condition known as resistant hypertension. Resistant hypertension refers to an aggressive form of high blood pressure, one that hasn't responded to treatment, and it's an area where, while we have some treatments available, the medical world is still looking...

We’re always in the process of adding new clinical studies to our program at AGA Clinical Trials, including common conditions impacting many people today, and a good example is our new resistant hypertension studies that we’re just beginning. Resistant hypertension is a particularly worrisome form of high blood pressure that impacts a number of Americans, but…

Clinical research trials are often targeted specifically at finding treatments, diagnosis methods or other important information about specific diseases or conditions, and one example here is Alzheimer’s disease. This harmful condition, which is known to affect older adults primarily and leads to several memory issues and often related health concerns, is the most common cause...

There are certain challenges the clinical trial industry as a whole is still working to overcome, and one of these is sex and gender disparities in clinical research trial enrollment. There has been significant research into this effect over the years, with the industry accepting that the disparity between males and females in trial recruitment...